J9278 — Injection, carboplatin (avyxa), 1 mg
J9278 is a HCPCS Level II code for injection, carboplatin (avyxa), 1 mg. It belongs to the Drugs Administered Other Than Oral Method section. Whether Medicare pays it depends on the coverage rule below.
Medicare coverage: Carrier judgment
Coverage is decided by your Medicare contractor, not by national policy. Whether this is paid depends on the LCD for your jurisdiction and on what the documentation supports.
From the coverage field of the CMS Alpha-Numeric HCPCS File, release 2026Q3-Jul. This states Medicare’s position on the code, not on your particular claim.
Physician fee schedule statusE
Excluded from the physician fee schedule by regulation. Payment, where it exists, comes from another fee schedule (drugs via ASP, supplies via DMEPOS, and so on).
Global period: XXX
Want the dollar amount for your locality? The fee calculator applies your GPCI and the current conversion factor.
The CMS record for J9278
- Long descriptor
- Injection, carboplatin (avyxa), 1 mg
- Short descriptor
- Inj, carboplatin (avyxa)
- Added
- April 1, 2026
- BETOS
- O1D
- Pricing indicator
- 51 — Other
The official wording. This is what the code means.
CMS's 28-character form, which is what shows up on a remittance advice.
When CMS introduced the code.
Berenson-Eggers Type of Service — CMS's own analytic grouping.
Drugs.
Codes adjacent to J9278
HCPCS has no hierarchy — related items simply sit next to each other in the numbering. If J9278 is not quite right, the correct code is very often within a few positions of it.
- J9270Injection, plicamycin, 2.5 mgterminated
- J9271Injection, pembrolizumab, 1 mg
- J9272Injection, dostarlimab-gxly, 10 mg
- J9273Injection, tisotumab vedotin-tftv, 1 mg
- J9274Injection, tebentafusp-tebn, 1 microgram
- J9275Injection, cosibelimab-ipdl, 2 mg
- J9276Injection, zanidatamab-hrii, 2 mg
- J9277Injection, pembrolizumab, 1 mg and berahyaluronidase alfa-pmph
- J9280Injection, mitomycin, 5 mg
- J9281Mitomycin pyelocalyceal instillation, 1 mg
- J9282Mitomycin, intravesical instillation, 1 mg
- J9285Injection, olaratumab, 10 mg
- J9286Injection, glofitamab-gxbm, 2.5 mg
- J9289Injection, nivolumab, 2 mg and hyaluronidase-nvhy
- J9292Injection, pemetrexed dipotassium, 10 mg
- J9293Injection, mitoxantrone hydrochloride, per 5 mg
Questions about J9278
What is HCPCS code J9278?
J9278 is a HCPCS Level II code for injection, carboplatin (avyxa), 1 mg. It sits in the Drugs Administered Other Than Oral Method section.
Does Medicare cover J9278?
The CMS HCPCS file marks J9278 as "Carrier judgment". Coverage is decided by your Medicare contractor, not by national policy. Whether this is paid depends on the LCD for your jurisdiction and on what the documentation supports.
How is J9278 paid under the physician fee schedule?
J9278 carries PFS status code E. Excluded from the physician fee schedule by regulation. Payment, where it exists, comes from another fee schedule (drugs via ASP, supplies via DMEPOS, and so on).